Latest Biotech News

Researchers publishing in Nature Communications unveiled an automated MRI system designed to detect clinically significant prostate cancer with high reliability. The team led by Wu, Liu and Yang...

An international team introduced a pan‑cancer detection method that pairs cell‑free DNA (cfDNA) fragment coverage with chromatin accessibility patterns to identify cancer across tumor types and...

A 2025 BMC Cancer study identified ASAH1 and altered sphingolipid metabolism as drivers of venetoclax resistance in acute myeloid leukemia (AML), particularly in monocytic phenotypes. The research...

Researchers launched CombiCoR‑Vax, a phase II trial testing a sequential immunotherapy‑then‑chemotherapy regimen in patients with refractory microsatellite‑stable (MSS) metastatic colorectal...

Eli Lilly reached a historic market valuation of $1 trillion after sustained gains tied to its obesity drug franchise. Market reports and company data show that demand for GLP-1–class medicines...

Resalis Therapeutics presented data and preclinical rationale for an antisense oligonucleotide (ASO) targeting miR‑22 that it says produces precision weight loss and metabolic benefits,...

Ginkgo Bioworks’ Ginkgo Datapoints unit announced the Virtual Cell Pharmacology Initiative (VCPI), an open‑source effort to standardize virtual cell modeling for drug discovery and generate...

Iambic, a San Diego–based company, reported that physics‑informed algorithms and automation have shortened its chemistry‑to‑clinic cycle to about two years, delivering small molecules into...

Novartis announced plans to establish a flagship manufacturing hub in North Carolina as part of a $23 billion U.S. infrastructure investment, adding biologics, sterile packaging, and solid‑dose...

The U.K. research funding agency ARIA named a former DARPA official, Fisher, as its new chief, according to BioCentury reporting. The appointment signals ARIA’s continued strategy of importing...

France‑based Ocean Diagnostics completed a pilot clinical evaluation showing its rapid sequencing–based blood test matched gold‑standard blood cultures at 100% concordance and detected additional...

Taiho Pharmaceutical and Cullinan Therapeutics initiated a rolling NDA submission to the U.S. FDA for zipalertinib, seeking accelerated approval for patients with locally advanced or metastatic...

Researchers published a thermally programmed one‑pot CRISPR assay that integrates thermal control with CRISPR molecular recognition to deliver rapid, sensitive viral detection suitable for on‑site...

Sydnexis received a complete response letter (CRL) from the FDA that prompted industry commentary about regulatory transparency and shifting review expectations, BioCentury reported. The company’s...

Ginkgo Bioworks’ Datapoints unit announced the Virtual Cell Pharmacology Initiative (VCPI), a community-driven open-source effort to standardize virtual cell modeling for drug discovery. Ginkgo...

France-based Ocean Diagnostics reported a pilot clinical evaluation showing its rapid bloodstream-infection test matched conventional blood cultures at 100% in a 110-patient ICU study at Bordeaux...

Eli Lilly became the first pharmaceutical company to reach a $1 trillion market valuation, driven largely by demand for its obesity medicines and strong commercial performance across its...

A BioCentury report on Sydnexis’ complete response letter (CRL) has reignited criticism about the FDA’s transparency and shifting review standards, and hundreds of biotech leaders have sent a...

Novartis unveiled plans to build a flagship North Carolina manufacturing hub with end-to-end biologics, sterile packaging and solid-dose capabilities, part of a $23 billion U.S. infrastructure...

Resalis Therapeutics presented preclinical and translational data at TIDES Europe showing an antisense oligonucleotide (ASO) targeting miR-22 that the company says drives durable, metabolically...